Symphony Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,013
Closed -$371K 175
2019
Q2
$371K Buy
+2,013
New +$360K 0.08% 122
2018
Q3
Sell
-4,546
Closed -$775K 185
2018
Q2
$775K Sell
4,546
-1,138
-20% -$201K 0.15% 131
2018
Q1
$969K Sell
5,684
-10,179
-64% -$1.87M 0.12% 168
2017
Q4
$2.76M Sell
15,863
-324
-2% -$57.3K 0.28% 85
2017
Q3
$3.02M Sell
16,187
-1,690
-9% -$299K 0.34% 73
2017
Q2
$3.08M Sell
17,877
-828
-4% -$135K 0.35% 70
2017
Q1
$3.07M Sell
18,705
-3,552
-16% -$590K 0.29% 82
2016
Q4
$3.25M Sell
22,257
-2,696
-11% -$406K 0.33% 73
2016
Q3
$4.16M Sell
24,953
-1,329
-5% -$225K 0.42% 53
2016
Q2
$4M Sell
26,282
-1,793
-6% -$279K 0.43% 66
2016
Q1
$4.21M Buy
28,075
+1,455
+5% +$216K 0.46% 52
2015
Q4
$4.32M Sell
26,620
-5,520
-17% -$868K 0.47% 47
2015
Q3
$4.45M Buy
32,140
+1,840
+6% +$290K 0.54% 43
2015
Q2
$4.65M Buy
30,300
+3,737
+14% +$599K 0.58% 43
2015
Q1
$4.25M Sell
26,563
-1,274
-5% -$201K 0.49% 47
2014
Q4
$4.43M Buy
27,837
+6,319
+29% +$985K 0.55% 41
2014
Q3
$3.02M Sell
21,518
-7,475
-26% -$976K 0.31% 68
2014
Q2
$3.43M Sell
28,993
-4,205
-13% -$487K 0.36% 77
2014
Q1
$4.09M Buy
33,198
+2,037
+7% +$247K 0.39% 67
2013
Q4
$3.56M Buy
31,161
+7,684
+33% +$874K 0.26% 75
2013
Q3
$2.63M Buy
23,477
+610
+3% +$66.1K 0.27% 89
2013
Q2
$2.26M Buy
+22,867
New +$2.37M 0.22% 108

Other funds holding AMGN

Symphony Asset Management's AMGN Position: Q3 2019 in Review

Symphony Asset Management sold out of Amgen (AMGN) in Q3 2019, closing a stake of 2,013 shares — an estimated $371K sold.

Symphony Asset Management first reported a position in AMGN in Q2 2013 and held it in 22 quarters. The position peaked at $4.65M in Q2 2015. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Symphony Asset Management reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Symphony Asset Management sold 2,013 Amgen shares in Q3 2019, an estimated $371K.
  • Symphony Asset Management first reported a position in Amgen in Q2 2013 and held it in 22 quarters.
  • Symphony Asset Management's Amgen position peaked at $4.65M in Q2 2015.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Symphony Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.